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Lysozyme is a naturally occurring enzyme found in bodily secretions such as tears, saliva, and milk. It functions as
an antimicrobial agent by cleaving the peptidoglycan component of bacterial cell walls, which leads to cell death.
Antibiotics are also antimicrobials and have been fed at subtherapeutic levels to swine as growth promoters. These
compounds benefit swine producers by minimizing production losses by increasing feed efficiency and decreasing
susceptibility to bacterial infection and disease. This manuscript reviews the knowledge of the effects of lysozyme,
as compared to traditional subtherapeutic antibiotics in swine feed, on pig performance and health. It is clear from
decades of studies that antibiotic use in feeds increases pig performance, particularly in the nursery. Similarly,
lysozyme, as a feed additive, increases growth and feed efficiency. While the mechanism by which antibiotics and
lysozyme improve performance is not clearly understood, both of these feed additives improve gastrointestinal
health, improve the metabolic profile, and alter the gastrointestinal bacteria ecology of swine. Therefore, lysozyme
is a suitable alternative to growth-promoting subtherapeutic antibiotic use in swine feed.
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Antimicrobials have been fed at subtherapeutic levels to
swine as growth promoters for more than 60 years, and
the majority of pigs produced in the U.S. receive antimi-
crobials in their feed at some point in their production
cycle. These compounds benefit swine producers by
minimizing production losses by increasing feed effi-
ciency and decreasing susceptibility to bacterial infection
and disease [1]. Wells et al. [2] observed 62 % prevalence
for Salmonella in swine prior to the growing phase of
production, and this number decreased to less than 15 %
after 8 weeks on diets containing chlortetracycline, a
broad based antimicrobial. In addition, increased Cam-
pylobacter shedding is associated with reduced perform-
ance in growing pigs [3]. Therefore, a reduction in
pathogen shedding due to antibiotic use appears to be
associated with increased animal performance. However,
in recent years, foreign and domestic markets have been
pressuring swine producers to reduce or remove antimi-
crobials from their diets.* Correspondence: William.Oliver@ars.usda.gov
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this article, unless otherwise stated.Lysozyme is a 1,4-β-N-acetylmuramidase that enzy-
matically cleaves a glycosidic linkage in the peptidogly-
can component of bacterial cell walls, which results in
the loss of cellular membrane integrity and cell death
[4]. In addition, hydrolysis products are capable of enhan-
cing immunoglobulin A (IgA) secretion, macrophage acti-
vation, and rapid clearance of bacterial pathogens [5, 6].
These data indicate that lysozyme may be a viable alterna-
tive to antibiotics in diets fed to swine.
Until recently, the literature pertaining to lysozyme as
a feed additive was limited to studies using transgenic
vectors to deliver lysozyme. These studies have shown
changes in metabolite profiles [7], intestinal microbiota
[8], and intestinal morphology [9] in pigs fed milk from
transgenic goats expressing human lysozyme in their
mammary gland. In addition, Humphrey et al. [10], re-
ported that diets supplemented with transgenic rice ex-
pressing lysozyme had antibiotic-like properties when
fed to chicks. While these reports are encouraging, the
delivery of lysozyme from transgenic goats’ milk or
transgenic rice is problematic in a swine production set-
ting. However, recent research with egg-white lysozyme
showed a performance benefit when fed to young pigs
[11–13].article is distributed under the terms of the Creative Commons Attribution
mons.org/licenses/by/4.0/), which permits unrestricted use, distribution,
you give appropriate credit to the original author(s) and the source,
ense, and indicate if changes were made. The Creative Commons Public
ommons.org/publicdomain/zero/1.0/) applies to the data made available in
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Before discovering penicillin, Alexander Fleming discov-
ered the enzyme lysozyme based on the ability of nasal
secretions to prohibit bacterial growth [14]. Lysozyme is
a naturally occurring enzyme found in bodily secretions
such as tears, saliva, and milk. It functions as an anti-
microbial by enzymatically cleaving a glycosidic linkage
of bacterial cell walls peptidoglycan, which leads to cell
death [4]. Lysozyme is found in many biological organ-
isms from bacteria and fungi to animal bodily secretions
and tissues [15, 16]. Lysozyme is an important defense
mechanism and is considered a part of the innate immune
system in most mammals [17], and is also an important
component of human breast milk [18]. However, due to
its very low concentration in sow milk (<0.065 μg/mL),
lysozyme is not believed to play a major role in the pre-
vention of infection in suckling pigs.
In vitro, lysozyme is generally considered effective
against some Gram-positive bacteria, but ineffective
against Gram-negative bacteria [19]. However, lysozyme,
perhaps indirectly, can affect Gram-negative bacteria
in vivo [11, 20]. Due to these antimicrobial properties,
lysozyme has been used effectively in the food industry
[21]. For example, it has been used in the cheese indus-
try to prevent late blowing [22, 23]. Lysozyme has also
been used as a preservative for other fresh foods [19], in-
cluding controlling meat spoilage [24].
Lysozyme is not currently used extensively as a feed
additive in the animal industry. However, its effective-
ness on pigs has been evaluated in different models.
Until recently, the literature pertaining to lysozyme as
a feed additive was limited to studies using milk from
transgenic organisms or transgenic rice to produce
and deliver the enzyme. Human lysozyme has been
expressed in the milk of pigs [25], mice [26], and goats
[8] as models for human medicine. Subsequent studies
using transgenic goats’ milk suggested that lysozyme
could be used as a feed antimicrobial. These studies have
shown changes in metabolite profiles [7], intestinal
microbiota [8], and intestinal morphology [9] in pigs fed
milk from transgenic goats expressing human lysozyme
in the mammary gland. Diets supplemented with trans-
genic rice expressing human lysozyme also improved the
performance of chicks [10]. These experiments were not
designed to evaluate lysozyme as a feed additive. How-
ever, results from recent experiments have shown that
lysozyme sourced from chicken eggs (Neova Technolo-
gies; Abbotsford, Canada) improved growth rate and
intestinal morphology and reduced Campylobacter
shedding in both 10-day-old pigs consuming a milk diet
[11] as well as nursery pigs [12, 13, 20]. In addition,
Nyachoti et al. [27] reported the same source of lyso-
zyme alleviated the piglet response to an oral challenge
of Escherichia coli K88.Lysozyme as a feed additive
Performance
The use of antibiotics in livestock feed is well established
and can improve growth rates in several species, includ-
ing swine [28–30]. The most important phenotypes for
any antimicrobial feed additives are weight gain and feed
efficiency. Studies using human lysozyme from trans-
genic goats’ milk did not show an improvement in
growth of pigs consuming human lysozyme [8, 9]. This
was likely due to the experimental design in these exper-
iments as they were not conducted to evaluate the effect
of lysozyme on pig performance. In these experiments,
growth improvement due to lysozyme was likely masked
due to the presence of antibiotics in both the control
and the experimental diet [9]. Presumably, Maga et al.
[8] fed diets that included antibiotics also. In addition,
both Brudige et al. [9] and Maga et al. [8] fed dry,
pelleted nursery diets in addition to the lysozyme-
containing goats’ milk. Thus, it is unclear how much
lysozyme was consumed by pigs in relation to the dry di-
ets in these studies. Due to the changes in intestinal
morphology and microflora, the pigs consumed a signifi-
cant amount of lysozyme, but this amount may not have
been sufficient to impact growth rate. Humphrey et al.
[10] fed 152 mg human lysozyme (produced from trans-
genic rice) per kg feed, but did not improve the growth
rate of chicks. However, the chicks had significantly im-
proved feed efficiency over those reared on a diet con-
taining neither the transgenic protein nor antibiotics.
Lysozyme sourced from chicken eggs improves growth
performance comparable to neomycin/oxytetracycline
(milk diets; [11]), carbadox/copper sulfate (nursery diets;
[12]) or chlortetracycline/tiamulin hydrogen fumarate
(nursery diets; [13]) compared with pigs consuming a
nonmedicated diet (Fig. 1). Due to the study design,
feeding group-housed pigs a milk diet, May et al. [11]
did not have the statistical power to detect changes in
feed efficiency. However, Oliver and Wells [12] and
Oliver et al. [13] were the first examples of lysozyme im-
proving feed efficiency in swine, where pigs consuming
lysozyme had an improved feed efficiency of about 8 %
compared with pigs consuming the untreated diet, which
was similar to pigs consuming the antibiotic-treated
feeds (Fig. 1).
Gastrointestinal tract
Improved villus height and crypt depth in the small in-
testine generally indicates improved intestinal health
[31–33]. However, due to the already rapidly changing
gross morphology in nursery pigs due to weaning, ob-
served changes in intestinal morphology due to dietary
subtherapeutic antibiotic are variable. Studies have shown
that some antibiotics improve morphology [12, 34]
whereas others do not [30, 35]. Previous work with human
Fig. 1 Average daily gain and feed efficiency of nursery pigs consuming control (non-mediated), control + antibiotics, or control + lysozyme diets
for 28 days. Nursery pigs consuming lysozyme or antibiotics gained weight approximately 8 % faster. In addition, pigs consuming either lysozyme
or antibiotics had improved feed efficiency of approximately 7 %. These data were adapted from Oliver and Wells [12] and Oliver et al. [13].
*Mean differs from control (P < 0.05)
Fig. 2 Villi height/crypt depth ratio of nursery pigs fed either a control
(non-medicated), control + antibiotics, or control + lysozyme diet for
28 days. Villi height increased and crypt depth decreased exclusively in
the jejunum of pigs consuming antibiotics or lysozyme, resulting in an
increase of approximately 70 % in villi height to crypt depth ratio.
These data were adapted from Oliver and Wells [12]. *Mean differs
from control (P < 0.05)
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did not show improvements in intestinal morphology in
the jejunum or ileum [9, 10, 36]. Cooper et al. [36] did
show a tendency for lysozyme to increase duodenal villi
height and observed a decrease in lamina propria thick-
ness. Similar to the lack of improvement in growth per-
formance in these studies, the lack of morphology
response is likely due to the concomitant presence of anti-
biotics in the feed, or simply a lower consumption of
lysozyme.
May et al. [11] and Oliver and Wells (Fig. 2; [12]) both
observed increased villus heights and crypt depths, indi-
cating improved intestinal health. However, the major
morphological responses in pigs consuming lysozyme or
antibiotics in liquid diets was observed in the ileum [11]
compared with responses seen exclusively in the je-
junum by Oliver and Wells [12]. Presumably, this is due
to the different physical forms of the diets consumed.
Major changes occur in the gastrointestinal tract in re-
sponse to the transition from a liquid to dry diet [37], in
particular to ion transport [38]. Presumably the changes
in structure and function of the small intestine allowed
lysozyme and antibiotics to have a greater effect on
the jejunum. Oliver and Wells et al. [12] observed de-
creased crypt depth in pigs consuming lysozyme or an-
tibiotics (Fig. 2), whereas they were increased in pigs
consuming lysozyme in liquid diets [11]. This is likely
due to the fact that cellular proliferation is very high in
the crypts in the younger animal, while villi enterocytes
are longer-lived in suckling animals compared with
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creased villi height in the ileum of pigs weaned at
17 days and fed an egg white source of lysozyme, but je-
junum morphology was not measured. Changes in ileal
morphology were likely due to the effect of the Escherichia
coli K88 challenge on the small intestine [27]. Taken to-
gether, these data indicate that this source of lysozyme
improves small intestinal morphology [11, 12, 27]. Im-
provements in small intestinal morphology may lead to a
greater absorptive capacity and be a mechanism by which
lysozyme and antibiotics improve growth rates.
Metabolites
Nutritional regime, health status, age, level of produc-
tion, and gastrointestinal microflora are a few examples
of the many factors that contribute to the metabolite
profile of an animal. It is clear that both lysozyme and
antibiotics alter many of these factors including growth
rate, microbiota (or at least individual organisms), and
gastrointestinal health. Circulating urea N is a reliable
indirect measurement to show the oxidation of dietary
amino acids in young pigs [40, 41]. Blood urea N (BUN)
is lower in pigs consuming either lysozyme or antibiotics
under a chronic immune challenge compared with con-
trol pigs [13]. This contradicts earlier work in non-
challenged pigs [12]. However, considering that pigs
consuming lysozyme or antibiotics accrued more protein
and consumed similar amounts of feed compared with
control pigs [13], the greater BUN was expected. There-
fore, presumably, pigs that consumed lysozyme or anti-
biotics utilized more of their dietary amino acids for
protein deposition than control pigs. Oliver and Wells
[12] likely had too few of animals to detect a response in
BUN.
The most efficient way to measure metabolites is
through metabolomic experiments. Brundige et al. [7]
found 18 known serum metabolites that were changed
by the consumption of lysozyme. Of these 18, most
changed in a direction that was decidedly “positive” for
pig health and(or) growth. Four of these (methionine,
threonine, hydroxyproline, and urea) indicate a propen-
sity for increased growth in pigs consuming lysozyme.
Methionine, threonine, and hydroxyproline increased in
serum indicating potential increases in protein synthesis
and skeletal growth, while serum urea decreased. These
findings support Oliver et al. [13], in that lysozyme con-
sumption increased growth rate and decreased circulat-
ing urea, in addition to an increase in protein accretion
compared with pigs consuming a non-medicated diet.
Cytokines and Immune Response
Immune system activation, including pro-inflammatory
cytokine and acute phase protein production, prevents an-
imals from reaching their genetic growth potential [42].For example, poultry and swine reared in germ-free envi-
ronments grow at a faster rate than animals reared in con-
ventional production environments [43, 44]. In addition,
utilizing a clean vs. a dirty environment to stimulate a
chronic immune response decreases animal performance
[45–47]. In pigs, an immune response does not generally
result in decreased feed conversion [48–50]. However,
both lysozyme [12] and antibiotics [1] improve feed effi-
ciency in nursery swine. In addition, Nyachoti et al. [27]
reported that lysozyme alleviated the piglet response to an
oral challenge of Escherichia coli K88, similar to trad-
itional antibiotics.
While cytokines primarily regulate the immune re-
sponse, they have an equal effect on nutrient metabol-
ism. During an immune response, pro-inflammatory
cytokines redirect nutrients away from growth and to-
ward the immune response [51, 52]. Although not the
only mode of action, cytokines increased both muscle
protein degradation and acute phase protein production
[53]. Cytokines and acute phase proteins were measured
in a study designed to elicit a low level immune re-
sponse, to both confirm the chronic immune stimulation
and to determine the effect of antibiotics and lysozyme
on the immune response [13]. Interleukin-6 and pig
major acute phase protein were unaffected by immune
status. In contrast, circulating levels of the cytokine
tumor necrosis factor-α (TNF-α) and the acute phase
proteins haptoglobin and C-reactive protein (CRP) were
higher in chronically immune stimulated pigs compared
with pigs reared in a clean nursery. These changes in cy-
tokines and acute phase proteins, as well as the perform-
ance changes observed, indicate that an acceptable level
of immune response was generated in pigs reared in the
dirty nursery to make inferences into the effect of antibi-
otics and lysozyme on chronically immune stimulated
pigs. Pigs consuming antibiotics or lysozyme had lower
TNF-α, haptoglobin, and CRP, compared with control
pigs, regardless of whether pigs were under chronic im-
mune stimulation or reared in a clean nursery. Similarly,
Lee et al. [54] observed lower haptoglobin levels in
antibiotic-fed pigs compared with non-medicated con-
trols. In addition, Nyachoti et al. [27] observed lower cir-
culating TNF-α levels post-challenge in pigs consuming
lysozyme. While these later studies used a different
model (acute Escherichia coli challenges), antibiotics and
lysozyme fed to pigs reduced the immune response
when exposed to pathogens. In addition to these studies,
Cooper et al. [36] determined that RNA for transforming
growth factor-β1 was increased in unchallenged pigs
consuming lysozyme from transgenic goats’ milk.
Microbial ecology
It is clear that the microbiota are important to pig health
and growth [26, 55]. However, Holman and Chenier [56]
Fig. 3 Campylobacter spp. shedding of nursery pigs fed either a
control (non-medicated), control + antibiotics, or control + lysozyme
diet for 28 days. Lysozyme, but not chlortetracyline/tiamulin in nursery
swine feed prevented the normal increase in campylobacter shedding
in the feces of nursery pigs. These data were adapted from Wells et al.
[20]. *Within day, mean differs from lysozyme (P < 0.05)
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in pigs consuming either tylosin or chlortetracycline.
Unno et al. [57] showed that the use of antibiotics in
swine feed inhibited potential pathogens. However, the
use of chlortetracycline, sulfathiazole, and penicillin did
not elicit a growth response making it impossible to de-
termine if the change in microbiota was associated with
improved performance. Clearly, more work in this area
is warranted.
It is now well documented that lysozyme has anti-
microbial qualities and improves pig performance and
gastrointestinal health. It is likely that lysozyme alters
the gastrointestinal bacterial population, either through
direct bacterial elimination (Gram-positive bacteria) or
changes to the ecology that favor one group of bacteria
over another. However, little work has been done look-
ing at the effect of lysozyme on pig gastrointestinal mi-
crobial populations. In a small, proof of concept
experiment, Maga et al. [8] observed that lysozyme was
capable of modulating the bacterial populations in the
duodenum and ileum of both kid goats and piglets. In
pigs, lysozyme from transgenic goats’ milk reduced both
total coliforms and E. coli in the duodenum, while only
total coliforms were reduced in the ileum. This small
study clearly shows that lysozyme has the ability to alter
microbial populations in vivo. Lysozyme was also shown
to reduce enterotoxigenic E. coli (ETEC) in challenged
piglets [27]. However, the observed effect of lysozyme on
E. coli species seems to be variable. The prevalence of
Shiga-toxigenic E. coli (STEC) is generally low in nursery
pigs [20] and was not altered by lysozyme or antibiotics.
The eae gene, which is an indicator gene for entero-
pathogenic and enterohemorrhagic E. coli (EPEC and
EHEC, respectively) is observed in nursery pigs [20].
However, this gene increases over the course of the nur-
sery phase, neither lysozyme or antibiotics seem to alter
its abundance [20]. The different observations due to
feeding lysozyme on E. coli may be due to the different
sources of lysozyme, different species of E. coli (ETEC
vs. STEC, EPEC, and EHEC), or the presence of a direct
E. coli K88 challenge [27].
Maga et al. [58] studied the microbiome of pigs con-
suming lysozyme expressed in transgenic goats’ milk.
Lysozyme decreased the levels of Firmicutes and in-
creased the levels of Bacteroidetes in pig feces. High
levels of Bacteroidetes are associated with decreased nu-
trient absorption [59], but the level of change in piglets
consuming lysozyme is unlikely to cause decreased ab-
sorption, especially considering the changes in gut
morphology and performance observed when feeding
lysozyme [12, 13]. At the taxonomic Family or Order
level, lysozyme decreased the abundance of bacteria as-
sociated with disease (Mycobacteriaceae, Streptococca-
ceae, and Campylobacterales) and increased bacteriaassociated with gastrointestinal health (Bifidobacteria-
ceae and Lactobacillaceae). These data support May
et al. [11] and Wells et al. (Fig. 3, [20]), who observed a
50 % reduction of Campylobacter spp. in pigs consum-
ing lysozyme compared with non-medicated pigs. While
carbadox/copper sulfate is effective against Campylobac-
ter spp. [3], Wells et al. [20] observed that chlortetracyc-
line/tiamulin hydrogen fumarate did not change the
Campylobacter spp. in the feces similar to lysozyme.Conclusions
It is clear that feeding subtherapeutic levels of antibiotics
improves performance and overall health and is used ex-
tensively throughout the swine industry. However, it is
also clear that swine producers are under pressure to re-
duce or eliminate the use of antibiotics due to concerns
over antibiotic resistance. Research into possible alterna-
tives is essential and will allow swine producers to keep
the animal well-being and monetary advantages of antibi-
otics without the perceived negative effects of their use.
Lysozyme is a natural antimicrobial already used in other
facets of the food industry. In nursery pigs, lysozyme
added to feed improves gastrointestinal health, reduces
potential pathogen shedding, and improves growth and
feed efficiency. Therefore, lysozyme is a viable alterna-
tive to traditional subtherapeutic antibiotic use in swine
production.
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